We Mean Business!

GreenStar continues to pursue opportunities in the area of transformational medicine and therapies that generate results and healing opportunities across multiple spectrums.

Eleusian Biosciences Corp.

GreenStar recently announced the acquisition of Eleusian Biosciences Corp, a Toronto based company, focused on the development of therapeutics for multiple pathological psychological diseases based on MDMA and psilocybin, plus NAcetylcysteine(NAC) compounds.

Eleusian is collaborating with a multidisciplinary team of scientists and physicians at the University of Miami to develop effective therapeutics for the treatment of mTBI (mild traumatic brain injury/concussion) with PTSD or PTSD alone based on the combination of Psilocybin (the active ingredient of psychedelic mushrooms) or MDMA and N-Acetylcysteine(NAC). NAC has been shown to have efficacy in treating mTBI, particularly in reducing neuronal losses and also reducing impaired cognitive and neurological symptoms after injury to head.

As a majority of patients with mTBI experience PTSD, we believe adding Psilocybin or MDMA to the mixture will be effective in addressing and suppressing or erasing pathological memories involved in PTSD. This combination may also elicit positive clinical outcomes in altering destructive behavior patterns such as drug and alcohol addiction, unconstrained mental and physical activity as Obsessive Compulsive Disorders (OCD), Alzheimer’s and Parkinson’s diseases, Autism, Schizophrenia, Depression and Bipolar Disorder.

Cowlitz County Cannabis Cultivation Inc.

GreenStar, through its subsidiary, currently owns certain assets including the property leases and intellectual property of Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”), a Tier 2 licensed cannabis producer and processor located in Washington State.  Washington State is one of many U.S. states where medical use of cannabis is legal and is one of the most mature cannabis markets in the U.S.  Cowlitz, one of the top processors in the state, continues to excel delivering innovative new products and brands to the market.  Cowlitz’s portfolio of branded products is broadly available at dispensaries and retailers across Washington State and it is one of the top 5 Tier 2 processors in Washington State.

Through strong relationships with growers, Cowlitz has been able to secure a consistent supply of quality cannabis to support its expanding operations and build a strong reputation in the industry.

Cowlitz offers proven operational expertise across many sectors of the recreational and medical cannabis value chain including processing and distribution.

Other Opportunities